Citations for
1IMD48, ZAP70
A novel Zap70 mutation with reduced protein stability demonstrates the rate-limiting threshold for Zap70 in T-cell receptor signalling.
Cauwe B, Tian L, Franckaert D, Pierson W, Staats KA, Schlenner SM, Liston A.
Immunology 141(3):377-87. doi: 10.1111/imm.12199. 2014
2IMD48, ZAP70
Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity.
Picard C, Dogniaux S, Chemin K, Maciorowski Z, Lim A, Mazerolles F, Rieux-Laucat F, Stolzenberg MC, Debre M, Magny JP, Le Deist F, Fischer A, Hivroz C.
Eur J Immunol 39(7):1966-76. 2009
3IMD48, ZAP70
Specific immunoglobulin E responses in ZAP-70-deficient patients are mediated by Syk-dependent T-cell receptor signalling.
Toyabe S, Watanabe A, Harada W, Karasawa T, Uchiyama M.
Immunology 103(2):164-71. 2001
4IMD48, ZAP70
Severe combined immunodeficiency due to a defect in the tyrosine kinase ZAP-70.
Elder ME.
Pediatr Res 39 : 743-748. 1996
5IMD48, ZAP70
ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency.
Chan AC, et al.
Science 264 : 1599-1601. 1994
6IMD48, ZAP70
Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase.
Elder ME, et al.
Science 264 : 1596-1599. 1994